Literature DB >> 9925946

Characterization and localization of the genes for mouse proteinase-3 (Prtn3) and neutrophil elastase (Ela2).

A Sturrock1, K F Franklin, S Wu, J R Hoidal.   

Abstract

Proteinase-3 (PR-3) and neutrophil elastase (NE) are polymorphonuclear leukocyte serine proteinases that degrade extracellular matrix proteins including elastin and appear to be involved in the pathogenesis of several diseases characterized by tissue destruction most notably emphysema and Wegener's granulomatosis. In this report we characterize and compare the mouse PR-3 and NE genes and establish by FISH analysis a common location on mouse chromosome 10C2. Each gene consists of five exons and four introns conserving the typical granule-associated serine proteinase gene structure. The mouse PR-3 gene (Prtn3) is approximately 3.7 kb and is within 2.2 kb of the smaller (1.7 kb) NE gene (Ela2). The larger size of Prtn3 is accounted for by differences in intron sizes. A comparison between the mouse and human PR-3 cDNA reveals 73% homology, however, this drops to 60% when the amino acid sequences are compared. Homology between the mouse and human NE cDNA is 77% for both the cDNA and amino acid sequences. The catalytic triad and its placement are conserved among the four genes. The proximal promoter of mouse Prtn3 contains a TATA box, c-myb and an ets transcriptional site. As these are functional elements in the mouse Ela2 promoter they may also be important in the expression of Prtn3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9925946     DOI: 10.1159/000015144

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  7 in total

1.  Comparative aspects of murine proteinase 3.

Authors:  Manfred Relle; Thomas Thomaidis; Peter R Galle; Andreas Schwarting
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

2.  C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats.

Authors:  W Weidebach; V S T Viana; E P Leon; C Bueno; A S Leme; F M Arantes-Costa; M A Martins; P H N Saldiva; E Bonfa
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

3.  Contributions to neutropenia from PFAAP5 (N4BP2L2), a novel protein mediating transcriptional repressor cooperation between Gfi1 and neutrophil elastase.

Authors:  Stephen J Salipante; Meghan E B Rojas; Brice Korkmaz; Zhijun Duan; Jeremy Wechsler; Kathleen F Benson; Richard E Person; H Leighton Grimes; Marshall S Horwitz
Journal:  Mol Cell Biol       Date:  2009-06-08       Impact factor: 4.272

4.  Absence of the proteoglycan decorin reduces glucose tolerance in overfed male mice.

Authors:  Jessica Svärd; Therese H Røst; Camilla E N Sommervoll; Christine Haugen; Oddrun A Gudbrandsen; Anne E Mellgren; Eyvind Rødahl; Johan Fernø; Simon N Dankel; Jørn V Sagen; Gunnar Mellgren
Journal:  Sci Rep       Date:  2019-03-15       Impact factor: 4.379

5.  Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis.

Authors:  Vivien R Sutton; Nigel J Waterhouse; Kylie A Browne; Karin Sedelies; Annette Ciccone; Desiree Anthony; Aulikki Koskinen; Arno Mullbacher; Joseph A Trapani
Journal:  J Cell Biol       Date:  2007-02-05       Impact factor: 10.539

6.  Gene expression analysis of a Helicobacter pylori-infected and high-salt diet-treated mouse gastric tumor model: identification of CD177 as a novel prognostic factor in patients with gastric cancer.

Authors:  Takeshi Toyoda; Tetsuya Tsukamoto; Masami Yamamoto; Hisayo Ban; Noriko Saito; Shinji Takasu; Liang Shi; Ayumi Saito; Seiji Ito; Yoshitaka Yamamura; Akiyoshi Nishikawa; Kumiko Ogawa; Takuji Tanaka; Masae Tatematsu
Journal:  BMC Gastroenterol       Date:  2013-07-30       Impact factor: 3.067

7.  Impact of microRNA-130a on the neutrophil proteome.

Authors:  Corinna Cavan Pedersen; Jan Christian Refsgaard; Ole Østergaard; Lars Juhl Jensen; Niels Henrik Helweg Heegaard; Niels Borregaard; Jack Bernard Cowland
Journal:  BMC Immunol       Date:  2015-11-25       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.